Summit Securities Group’s YD Bio Ltd Warrants YDESW Stock Holding History

Summit Securities Group’s Portfolio YDESW Stock Details YDESW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1	Closed	-$1	–	1415
2026 Q1	$1	Hold	1	–	–	﹤0.01%	1015
2025 Q4	$1	Buy	+1	New	+$1	﹤0.01%	986

Other funds holding YDESW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return

Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

True North Advisors Dallas, Texas $1.35B AUM 15.32% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Aristeia Capital Greenwich, Connecticut $7.69B AUM 15.48% 1-Year Est. Return

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

Summit Securities Group's YDESW Position: Q2 2026 in Review

Summit Securities Group sold out of YD Bio Ltd Warrants (YDESW) in Q2 2026, closing a stake of 1 share — an estimated $1 sold.

Summit Securities Group first reported a position in YDESW in Q4 2025 and held it in 2 quarters. The position peaked at $1 in Q1 2026. 8 funds tracked by Wall St. Rank hold YDESW as of Q2 2026.

Summit Securities Group reported no remaining YD Bio Ltd Warrants position as of Q2 2026 after selling out during the quarter.
Summit Securities Group sold 1 YD Bio Ltd Warrants share in Q2 2026, an estimated $1.
Summit Securities Group first reported a position in YD Bio Ltd Warrants in Q4 2025 and held it in 2 quarters.
Summit Securities Group's YD Bio Ltd Warrants position peaked at $1 in Q1 2026.
8 funds tracked by Wall St. Rank held YD Bio Ltd Warrants as of Q2 2026.

Based on Summit Securities Group's 13F filing for Q2 2026, filed 3 Aug 2026.